243 related articles for article (PubMed ID: 16461300)
41. Platelet Toll-Like Receptors Mediate Thromboinflammatory Responses in Patients With Essential Thrombocythemia.
Marín Oyarzún CP; Glembotsky AC; Goette NP; Lev PR; De Luca G; Baroni Pietto MC; Moiraghi B; Castro Ríos MA; Vicente A; Marta RF; Schattner M; Heller PG
Front Immunol; 2020; 11():705. PubMed ID: 32425934
[TBL] [Abstract][Full Text] [Related]
42. Altered plasma fibrin clot properties in essential thrombocythemia.
Małecki R; Gacka M; Kuliszkiewicz-Janus M; Jakobsche-Policht U; Kwiatkowski J; Adamiec R; Undas A
Platelets; 2016; 27(2):110-6. PubMed ID: 25989112
[TBL] [Abstract][Full Text] [Related]
43. Tissue factor in patients with acute coronary syndromes: expression in platelets, leukocytes, and platelet-leukocyte aggregates.
Brambilla M; Camera M; Colnago D; Marenzi G; De Metrio M; Giesen PL; Balduini A; Veglia F; Gertow K; Biglioli P; Tremoli E
Arterioscler Thromb Vasc Biol; 2008 May; 28(5):947-53. PubMed ID: 18292391
[TBL] [Abstract][Full Text] [Related]
44. Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history.
Gangat N; Wassie EA; Lasho TL; Finke C; Ketterling RP; Hanson CA; Pardanani A; Wolanskyj AP; Maffioli M; Casalone R; Passamonti F; Tefferi A
Eur J Haematol; 2015 Jan; 94(1):31-6. PubMed ID: 24889737
[TBL] [Abstract][Full Text] [Related]
45. The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia vera.
Tefferi A; Lasho TL; Schwager SM; Strand JS; Elliott M; Mesa R; Li CY; Wadleigh M; Lee SJ; Gilliland DG
Cancer; 2006 Feb; 106(3):631-5. PubMed ID: 16369984
[TBL] [Abstract][Full Text] [Related]
46. Nitric oxide derivatives and soluble plasma selectins in patients with myeloproliferative neoplasms.
Cella G; Marchetti M; Vianello F; Panova-Noeva M; Vignoli A; Russo L; Barbui T; Falanga A
Thromb Haemost; 2010 Jul; 104(1):151-6. PubMed ID: 20431848
[TBL] [Abstract][Full Text] [Related]
47. V617F JAK-2 mutation in patients with essential thrombocythemia: relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules.
Falanga A; Marchetti M; Vignoli A; Balducci D; Russo L; Guerini V; Barbui T
Exp Hematol; 2007 May; 35(5):702-11. PubMed ID: 17577920
[TBL] [Abstract][Full Text] [Related]
48. Blast phase of essential thrombocythemia: A single center study.
Passamonti F; Rumi E; Arcaini L; Elena C; Castagnola C; Zappasodi P; Bernasconi P; Pietra D; Pascutto C; Cazzola M; Lazzarino M
Am J Hematol; 2009 Oct; 84(10):641-4. PubMed ID: 19691103
[TBL] [Abstract][Full Text] [Related]
49. Extrinsic blood coagulation pathway and risk factors for thrombotic events in patients with essential thrombocythemia.
Stankowska K; Gadomska G; Boinska J; Michalska M; Bartoszewska-Kubiak A; Rość D
Pol Arch Med Wewn; 2016 May; 126(5):340-6. PubMed ID: 27243342
[TBL] [Abstract][Full Text] [Related]
50. Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia.
Antonioli E; Guglielmelli P; Poli G; Bogani C; Pancrazzi A; Longo G; Ponziani V; Tozzi L; Pieri L; Santini V; Bosi A; Vannucchi AM;
Haematologica; 2008 Jan; 93(1):41-8. PubMed ID: 18166784
[TBL] [Abstract][Full Text] [Related]
51. Platelet mass cytometry reveals dysregulation of prothrombotic pathways in essential thrombocythemia.
Dill V; Kirmes K; Han J; Klug M; Rosenbaum M; Viggiani G; von Scheidt M; List M; Herhaus P; Ruland J; Bassermann F; Laugwitz KL; Götze KS; Jost PJ; Jilg S; Bloxham CJ; Raake PWJ; Bernlochner I; Bongiovanni D
Platelets; 2024 Dec; 35(1):2358244. PubMed ID: 38845541
[TBL] [Abstract][Full Text] [Related]
52. Increases in circulating levels of monocyte-platelet and neutrophil-platelet complexes following hip arthroplasty.
Bunescu A; Widman J; Lenkei R; Menyes P; Levin K; Egberg N
Clin Sci (Lond); 2002 Mar; 102(3):279-86. PubMed ID: 11869168
[TBL] [Abstract][Full Text] [Related]
53. Increased leukocyte-platelet interactions during circulatory support with left ventricular assist devices.
Radovancevic R; Matijevic N; Bracey AW; Radovancevic B; Elayda M; Gregoric ID; Frazier OH
ASAIO J; 2009; 55(5):459-64. PubMed ID: 19730003
[TBL] [Abstract][Full Text] [Related]
54. Recurrent der(9;18) in essential thrombocythemia with JAK2 V617F is highly linked to myelofibrosis development.
Ohyashiki K; Kodama A; Ohyashiki JH
Cancer Genet Cytogenet; 2008 Oct; 186(1):6-11. PubMed ID: 18786436
[TBL] [Abstract][Full Text] [Related]
55. Proteomic study of the impact of the JAK2-V617F mutation on the phenotype of essential thrombocythemia.
Mossuz P; Arlotto M; Hermouet S; Bouamrani A; Lippert E; Girodon F; Dobo I; Vincent P; Cahn JY; Berger F
Exp Hematol; 2008 Dec; 36(12):1642-7. PubMed ID: 18838204
[TBL] [Abstract][Full Text] [Related]
56. Clinical implications of the JAK2 V617F mutation in essential thrombocythemia.
Antonioli E; Guglielmelli P; Pancrazzi A; Bogani C; Verrucci M; Ponziani V; Longo G; Bosi A; Vannucchi AM
Leukemia; 2005 Oct; 19(10):1847-9. PubMed ID: 16079890
[No Abstract] [Full Text] [Related]
57. Correlation between leukocytosis and thrombosis in Philadelphia-negative chronic myeloproliferative neoplasms.
Caramazza D; Caracciolo C; Barone R; Malato A; Saccullo G; Cigna V; Berretta S; Schinocca L; Quintini G; Abbadessa V; Di Raimondo F; Siragusa S
Ann Hematol; 2009 Oct; 88(10):967-71. PubMed ID: 19214510
[TBL] [Abstract][Full Text] [Related]
58. JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis.
De Stefano V; Rossi E; Za T; Ciminello A; Betti S; Luzzi C; Leone G; Chiusolo P
Am J Hematol; 2011 Jun; 86(6):526-8. PubMed ID: 21594892
[No Abstract] [Full Text] [Related]
59. Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemia.
Musolino C; Allegra A; Saija A; Alonci A; Russo S; Spatari G; Penna G; Gerace D; Cristani M; David A; Saitta S; Gangemi S
Clin Biochem; 2012 Nov; 45(16-17):1439-43. PubMed ID: 22850610
[TBL] [Abstract][Full Text] [Related]
60. Predictive factors of thrombosis for patients with essential thrombocythaemia: A single center study.
Prajs I; Kuliczkowski K
Adv Clin Exp Med; 2017; 26(1):115-121. PubMed ID: 28397442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
